Once- or twice-daily thoracic radiation in limited-stage small-cell lung cancer treated with concurrent chemoradiotherapy.

ABSTRACT:

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of once-daily radiotherapy versus twice-daily radiotherapy concurrently with chemotherapy for optimal survival outcomes in people with limited-stage small-cell lung cancer (LS-SCLC).

SUBMITTER: Harada K 

PROVIDER: S-EPMC12461785 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature